O

Ocugen
D

OCGN

0.68000
USD
-0.02
(-2.86%)
مغلق
حجم التداول
27,142
الربح لكل سهم
-0
العائد الربحي
-
P/E
-4
حجم السوق
197,843,923
نظرة عامةالتوصياتالأفكار والتحليلاتالأخبار
أصول ذات صلة
    A
    ADVM
    -0.03500
    (-0.88%)
    3.95000 USD
    A
    ALT
    -0.19000
    (-2.87%)
    6.42000 USD
    BNTX
    BNTX
    2.240
    (1.90%)
    120.100 USD
    C
    CODX
    0.01720
    (2.46%)
    0.71700 USD
    I
    INO
    0.02000
    (0.91%)
    2.23000 USD
    MRNA
    MRNA
    1.785
    (5.29%)
    35.535 USD
    N
    NVAX
    0.05500
    (0.69%)
    7.98000 USD
    V
    VXRT
    0.00670
    (0.95%)
    0.70980 USD
    المزيد
الأخبار
المقالات

العنوان: Ocugen

القطاع: Healthcare
الصناعة: Biotechnology
Ocugen Inc company focused on discovering, developing, and commercializing novel gene and cell therapies and vaccines that improve health and offer hope for patients across the globe. The company's pipeline includes Modifier Gene Therapy Platform, Novel Biologic Therapy for Retinal Diseases, Regenerative Medicine Cell Therapy Platform. The company is developing a modifier gene therapy platform designed to fulfill unmet medical needs related to retinal diseases, including inherited retinal diseases ("IRDs"), such as RP, LCA, Stargardt disease, and multifactorial diseases such as dAMD and Geographic Atrophy ("GA").